Bristol-Myers Squibb Rises On Unusually High Volume (BMY)
Bristol-Myers Squibb Company (NYSE:BMY) is trading at unusually high volume Thursday with 17.8 million shares changing hands. It is currently at 2.1 times its average daily volume and trading up 91 cents (+2.6%).
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Bristol-Myers Squibb Company (NYSE: BMY) is trading at unusually high volume Thursday with 17.8 million shares changing hands. It is currently at 2.1 times its average daily volume and trading up 91 cents (+2.6%) at $35.81 as of 3:21 p.m. ET.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Bristol-Myers Squibb has a market cap of $57.53 billion and is part of the health care sector and drugs industry. Shares are up 5.7% year to date as of the close of trading on Wednesday. Bristol-Myers Squibb Company, a biopharmaceutical company, discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products that help patients prevail over serious diseases worldwide. The company has a P/E ratio of 31.4, above the S&P 500 P/E ratio of 17.7. TheStreet Ratings rates Bristol-Myers Squibb as a buy. The company's strengths can be seen in multiple areas, such as its good cash flow from operations, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. You can view the full Bristol-Myers Squibb Ratings Report. See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center. It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.